Latest stories on ARTL
Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain
Business Insider58 · neutralproduct/pr
ARTELO BIOSCIENCES, INC. (ARTL) files 8-K
SEC 8-K50 · neutralgeneral
Artelo’s first BIO-Europe company presentation spotlights ART26.12’s Phase 1 safety profile and dosing flexibility
MarketChameleon63 · neutralproduct/pr
ARTL files obesity patent after mouse study showed ~40% weight loss with semaglutide combo
September 24, 2026
MarketChameleon67 · bullishproduct/pr
Why Is Penny Stock Artelo Biosciences (ARTL) Up Over 200% Today?
TipRanks63 · neutralproduct/pr
Artelo Biosciences announces results from nonclinical study of ART27.13
The Fly59 · neutralproduct/pr
Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
Artelo Biosciences Inc trading halted, news pending
The Fly48 · neutralgeneral
ARTELO BIOSCIENCES, INC. (ARTL) files 8-K
SEC 8-K50 · neutralgeneral
Artelo Biosciences announces 1-for-9 reverse stock split
The Fly25 · bearishgeneral
Artelo Biosciences Announces Reverse Stock Split
GlobeNewswire25 · bearishgeneral
Artelo Biosciences Announces Reverse Stock Split
Business Insider25 · bearishgeneral
Artelo secures Japan patent allowance for ART27.13 commercial formulation
The Fly63 · neutralproduct/pr
Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
GlobeNewswire63 · neutralproduct/pr
Artelo Biosciences receives notice of allowance from USPTO
The Fly62 · neutralgeneral
Artelo Biosciences GAAP EPS of -$0.89
Seeking Alpha28 · bearishearnings
Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
Business Insider55 · neutralearnings